TuHURA Biosciences plunges after $15.6 million direct stock deal

TuHURA Biosciences

09/12/2025 15:56

** Drug developer TuHURA Biosciences' HURA.O shares plunge 36.9% to $1.25

** HURA enters agreement for sale of ~9.5 million shares, Series A warrants, and Series B warrants in a registered direct offering at a purchase price of $1.65 apiece for gross proceeds of $15.6 million

** H.C. Wainwright is the exclusive lead placement agent for offering

** Closing of the offering is expected to occur in three tranches

** Proceeds from the offering will be used for working capital and general purposes

** All three analysts covering the stock rate it "buy"; median PT $9.13 - data compiled by LSEG

** As of last close, HURA stock down 51.6% YTD

 (Reporting by Arasu Kannagi Basil in Bengaluru)

 ((ArasuKannagi.Basil@thomsonreuters.com))